Togo Confirms First Coronavirus Case
U.S officials on Monday said the first human trial to evaluate a candidate vaccine against coronavirus disease 2019 has begun in Seattle.
The US National institutes of Health in a statement said “The open-label trial will enrol 45 healthy adult volunteers ages 18 to 55 years over approximately 6 weeks,”.
“The first participant received the investigational vaccine today.”
NNPCL reduces petrol price to ₦965 in Abuja. Independent marketers maintain higher prices, ranging from…
The Federal Government has declared Wednesday, Thursday and Jan.1, 2025 as public holidays. This was…
The Minister of State for Defence, Bello Matawalle, says the lifting of ban on mining…